Introduction

hibernicor_mainimg5.jpg
Margaret Billingham, MD, died in 2009 at age 78 following a career as the world’s preeminent cardiac pathologist - having developed the grading criteria used to grade heart transplant rejection. With her grace and calm demeanor she changed the entire field of cardiac transplantation.

Hibernicor, LLC is a medical technology company committed to providing the benchmark of quality and leads the industry in FDA and CE compliance. Hibernicor is dedicated to improving medical care through research and product development. The company supports standard of care guidelines and best practices in organ procurement to meet the needs of patients and physicians.


Recent Headlines

16 Jun 2009 Semi-finalist - 2009 Minnesota Cup business plan competition
13 Nov 2008 Dr. Rivard weighs in at the OPTN organ allocation debate
31 Oct 2008 Pre-clinical research protocol finalized with the FDA.
13 May 2008 European initiative kickoff in Germany
01 May 2008 Research study shows that Asporto limits degredation of the donor heart.
03 Mar 2008 “Hibernicor” is a registered service mark
28 Sep 2007 FDA and Hibernicor to have a pre-IDE meeting